• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实施重大手术后电子警报和生物标志物引导的肾脏保护策略后的肾脏恢复情况

Renal Recovery after the Implementation of an Electronic Alert and Biomarker-Guided Kidney-Protection Strategy following Major Surgery.

作者信息

Halmy Laszlo, Riedel Joshua, Zeman Florian, Tege Birgit, Linder Volker, Gnewuch Carsten, Graf Bernhard M, Schlitt Hans J, Bergler Tobias, Göcze Ivan

机构信息

Department of Surgery, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany.

Medical Faculty, University of Regensburg, Universitätsstraße 31, 93053 Regensburg, Germany.

出版信息

J Clin Med. 2021 Oct 31;10(21):5122. doi: 10.3390/jcm10215122.

DOI:10.3390/jcm10215122
PMID:34768642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8584790/
Abstract

The facilitation of early recovery of acute kidney injury (AKI) is an important step to improve outcome, particularly because of the limited therapeutic interventions currently available for AKI. The combination of an electronic alert and biomarker-guided kidney-protection strategy implemented in the routine care may have an impact on the incidence of early complete reversal of AKI after major non-cardiac surgery. We studied 294 patients in two cohorts before ( = 151) and after protocol implementation ( = 143). Data collection required 6 months for each cohort. The kidney-protection protocol included an electronic alert to detect patients who were eligible for urinary biomarker [TIMP2 × IGFBP7]-guided kidney-protection intervention. Intervention was stratified according to three levels of immediate AKI risk: low, moderate, and high. After intervention, postoperative changes in the glomerular filtration rate (eGFR) were identified with a tracking software that included an alert for nephrology consultation if the eGFR had declined by >25% from the preoperative reference value. Primary outcome was early AKI recovery, i.e., the complete reversal of any AKI stage to absence of AKI within the first 7 postoperative days. Protocol implementation significantly increased the recovery of AKI (36/46, 78% compared to control 27/48, 56%, ( = 0.025)) and reduced the length of the ICU stay ( < 0.001). There was no significant difference in the overall incidence of all AKI and moderate and severe AKI in the first 7 postoperative days: 46/143 (32%) and 12/151 (8%) in the protocol implementation group compared to 48/151 (32%) and 18/151 (12%) in the historical control group. Patients with AKI reversal within the first 7 postoperative days had lower in-hospital mortality than patients without AKI reversal. Implementing a combined electronic alert and biomarker-guided kidney-protection strategy in routine care improved early recovery of AKI after major surgery.

摘要

促进急性肾损伤(AKI)的早期恢复是改善预后的重要一步,特别是考虑到目前针对AKI的治疗干预措施有限。在常规护理中实施电子警报和生物标志物引导的肾脏保护策略,可能会对重大非心脏手术后AKI早期完全逆转的发生率产生影响。我们在两个队列中研究了294例患者,一个队列是在方案实施前(n = 151),另一个队列是在方案实施后(n = 143)。每个队列的数据收集需要6个月。肾脏保护方案包括一个电子警报,以检测符合尿生物标志物[TIMP2×IGFBP7]引导的肾脏保护干预条件的患者。干预根据急性肾损伤的三个即时风险水平进行分层:低、中、高。干预后,使用跟踪软件识别肾小球滤过率(eGFR)的术后变化,如果eGFR较术前参考值下降>25%,该软件会发出肾脏科会诊警报。主要结局是AKI的早期恢复,即在术后第1个7天内将任何AKI阶段完全逆转至无AKI。方案实施显著提高了AKI的恢复率(36/46,78%,而对照组为27/48,56%,P = 0.025),并缩短了ICU住院时间(P < 0.001)。术后第1个7天内所有AKI以及中度和重度AKI的总体发生率无显著差异:方案实施组为46/143(32%)和12/151(8%),历史对照组为48/151(32%)和18/151(12%)。术后第1个7天内发生AKI逆转的患者的住院死亡率低于未发生AKI逆转的患者。在常规护理中实施电子警报和生物标志物引导的联合肾脏保护策略可改善重大手术后AKI的早期恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9e/8584790/941259381416/jcm-10-05122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9e/8584790/ccb9b9a8628b/jcm-10-05122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9e/8584790/183eb67d2b90/jcm-10-05122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9e/8584790/941259381416/jcm-10-05122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9e/8584790/ccb9b9a8628b/jcm-10-05122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9e/8584790/183eb67d2b90/jcm-10-05122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9e/8584790/941259381416/jcm-10-05122-g003.jpg

相似文献

1
Renal Recovery after the Implementation of an Electronic Alert and Biomarker-Guided Kidney-Protection Strategy following Major Surgery.实施重大手术后电子警报和生物标志物引导的肾脏保护策略后的肾脏恢复情况
J Clin Med. 2021 Oct 31;10(21):5122. doi: 10.3390/jcm10215122.
2
Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study.生物标志物指导的干预措施预防大手术后急性肾损伤:前瞻性随机 BigpAK 研究。
Ann Surg. 2018 Jun;267(6):1013-1020. doi: 10.1097/SLA.0000000000002485.
3
Impact of Electronic Acute Kidney Injury (AKI) Alerts With Automated Nephrologist Consultation on Detection and Severity of AKI: A Quality Improvement Study.电子急性肾损伤 (AKI) 警报与自动肾脏病专家咨询对 AKI 的检测和严重程度的影响:一项质量改进研究。
Am J Kidney Dis. 2018 Jan;71(1):9-19. doi: 10.1053/j.ajkd.2017.06.008. Epub 2017 Jul 25.
4
Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.尿 [TIMP-2]·[IGFBP7] 指导的随机对照干预试验,以预防急诊科急性肾损伤。
Nephrol Dial Transplant. 2019 Nov 1;34(11):1902-1909. doi: 10.1093/ndt/gfy186.
5
(TIMP2) x (IGFBP7) as early renal biomarker for the prediction of acute kidney injury in aortic surgery (TIGER). A single center observational study.TIMP2(组织金属蛋白酶抑制剂 2)与 IGFBP7(胰岛素样生长因子结合蛋白 7)作为主动脉手术中急性肾损伤预测的早期肾生物标志物(TIGER)。一项单中心观察性研究。
PLoS One. 2021 Jan 7;16(1):e0244658. doi: 10.1371/journal.pone.0244658. eCollection 2021.
6
Increase of urinary TIMP-2 and IGFBP7 as potential predictor of acute kidney injury requiring renal replacement therapy and patients' outcome following complex endovascular and open thoracic abdominal aortic aneurysm surgery - a prospective observational study.尿 TIMP-2 和 IGFBP7 的增加可作为复杂血管内和开放胸腹主动脉瘤手术后需要肾脏替代治疗的急性肾损伤和患者预后的潜在预测指标 - 一项前瞻性观察研究。
Vasa. 2021 Feb;50(2):101-109. doi: 10.1024/0301-1526/a000902. Epub 2020 Aug 20.
7
Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients.利用电子结果报告诊断和监测住院患者的 AKI。
Clin J Am Soc Nephrol. 2012 Apr;7(4):533-40. doi: 10.2215/CJN.08970911. Epub 2012 Feb 23.
8
Using urinary biomarkers to reduce acute kidney injury following cardiac surgery.应用尿生物标志物减少心脏手术后急性肾损伤。
J Thorac Cardiovasc Surg. 2020 Nov;160(5):1235-1246.e2. doi: 10.1016/j.jtcvs.2019.10.034. Epub 2019 Oct 17.
9
Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.尿组织金属蛋白酶抑制因子-2和胰岛素样生长因子结合蛋白7作为心脏手术后急性肾损伤及肾脏恢复的早期生物标志物。
PLoS One. 2014 Mar 27;9(3):e93460. doi: 10.1371/journal.pone.0093460. eCollection 2014.
10
Electronic Acute Kidney Injury Alert at the Brandenburg Medical School: Implementation and Follow-Up.勃兰登堡医科大学电子急性肾损伤警报:实施与随访。
Kidney Blood Press Res. 2023;48(1):701-709. doi: 10.1159/000534158. Epub 2023 Oct 28.

引用本文的文献

1
The influence of electronic AKI alert on prognosis of adult hospitalized patients: a systematic review and meta-analysis.电子急性肾损伤警报对成年住院患者预后的影响:一项系统评价和荟萃分析。
Crit Care. 2025 May 12;29(1):189. doi: 10.1186/s13054-025-05402-x.
2
Biomarkers in pursuit of precision medicine for acute kidney injury: hard to get rid of customs.用于急性肾损伤精准医学的生物标志物:难以摆脱传统观念。
Kidney Res Clin Pract. 2024 Jul;43(4):393-405. doi: 10.23876/j.krcp.23.284. Epub 2024 Jun 25.
3
Failing kidneys: renal replacement therapies in the ICU.

本文引用的文献

1
Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial.电子健康记录急性肾损伤警报:多中心、随机临床试验。
BMJ. 2021 Jan 18;372:m4786. doi: 10.1136/bmj.m4786.
2
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement.急性疾病质量倡议共识会议关于急性肾损伤生物标志物的建议:共识声明。
JAMA Netw Open. 2020 Oct 1;3(10):e2019209. doi: 10.1001/jamanetworkopen.2020.19209.
3
Real-Time Prediction of Acute Kidney Injury in Hospitalized Adults: Implementation and Proof of Concept.
肾衰竭:重症监护病房中的肾脏替代治疗
Trauma Surg Acute Care Open. 2024 Apr 15;9(Suppl 2):e001381. doi: 10.1136/tsaco-2024-001381. eCollection 2024.
4
Automated Electronic Alert for the Care and Outcomes of Adults With Acute Kidney Injury: A Randomized Clinical Trial.自动化电子警报在成人急性肾损伤的护理和结局中的应用:一项随机临床试验。
JAMA Netw Open. 2024 Jan 2;7(1):e2351710. doi: 10.1001/jamanetworkopen.2023.51710.
5
Impact of renal recovery on in-hospital and post-discharge mortality.肾功能恢复对住院期间和出院后死亡率的影响。
Rev Esc Enferm USP. 2023 Dec 4;57:e20230144. doi: 10.1590/1980-220X-REEUSP-2023-0144en. eCollection 2023.
6
Improvement of composite kidney outcomes by AKI care bundles: a systematic review and meta-analysis.AKI 护理包对改善复合肾脏结局的系统评价和荟萃分析。
Crit Care. 2023 Oct 9;27(1):390. doi: 10.1186/s13054-023-04641-0.
实时预测住院成人急性肾损伤:实施与概念验证。
Am J Kidney Dis. 2020 Dec;76(6):806-814.e1. doi: 10.1053/j.ajkd.2020.05.003. Epub 2020 Jun 4.
4
Transient and Persistent AKI and Outcomes in Patients Undergoing Major Abdominal Surgery.主要腹部手术后一过性和持续性急性肾损伤及结局。
Nephron. 2020;144(5):236-244. doi: 10.1159/000506397. Epub 2020 Apr 21.
5
Defining Major Surgery: A Delphi Consensus Among European Surgical Association (ESA) Members.定义大手术:欧洲外科协会(ESA)成员的德尔菲共识。
World J Surg. 2020 Jul;44(7):2211-2219. doi: 10.1007/s00268-020-05476-4.
6
Use of Biomarkers to Detect and Manage Acute Kidney Injury: Has Progress Stalled?利用生物标志物检测和管理急性肾损伤:进展停滞了吗?
Clin Chem. 2020 Feb 1;66(2):271-276. doi: 10.1093/clinchem/hvz026.
7
Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel.[TIMP-2]•[IGFBP7] 生物标志物检测在重症监护中评估急性肾损伤风险的临床应用:专家小组的指导意见。
Crit Care. 2019 Jun 20;23(1):225. doi: 10.1186/s13054-019-2504-8.
8
An Organizational-Level Program of Intervention for AKI: A Pragmatic Stepped Wedge Cluster Randomized Trial.急性肾损伤的组织层面干预方案:一项实用型阶梯式楔形集群随机试验。
J Am Soc Nephrol. 2019 Mar;30(3):505-515. doi: 10.1681/ASN.2018090886. Epub 2019 Feb 21.
9
Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.组织金属蛋白酶抑制剂 2(TIMP-2) • 胰岛素样生长因子结合蛋白 7(IGFBP7)水平与重症监护病房急性肾损伤患者的不良预后相关。
Kidney Int. 2019 Jun;95(6):1486-1493. doi: 10.1016/j.kint.2019.01.020. Epub 2019 Mar 9.
10
Mechanisms Underlying Increased TIMP2 and IGFBP7 Urinary Excretion in Experimental AKI.实验性 AKI 中 TIMP2 和 IGFBP7 尿排泄增加的机制。
J Am Soc Nephrol. 2018 Aug;29(8):2157-2167. doi: 10.1681/ASN.2018030265. Epub 2018 Jul 6.